CAD & Atherosclerosis
Feature
ISCHEMIA substudy data don’t add up, cardiac surgeons say
Discrepancies between the paper and supplemental data have been slow to come to light, but the substudy authors say it’s a simple formatting error...
News
FDA approves Medtronic’s Onyx Frontier drug-eluting stent
The low-profile stent shares the same platform as the previous-generation Resolute Onyx zotarolimus-eluting stent and features an enhanced...
From the Journals
Reduced exercise capacity predicted mortality in COPD
From the Journals
Espresso coffee linked to increased total cholesterol
Drinking espresso coffee is linked to higher total cholesterol levels, particularly in men, new observational data show.
Latest News
‘Critical window’ to intervene for weight issues in early childhood
“Detection needs to start as early as age 2-5 years because if you wait just a few years longer these children will show early signs of disease...
From the Journals
‘Embarrassing’: High-intensity statin uptake in ASCVD patients ‘terrible’
A national study uncovered abysmal rates of usage for one of the most studied and inexpensive therapies available.
Latest News
Experts show how to reduce school-related sedentary behavior
“These recommendations will be useful in supporting the physical and mental health, well-being, and academic success of school-age children and...
From the Journals
Traumatic brain injury linked to ‘striking’ risk for CVD, diabetes, brain disorders
Mild and moderate-to-severe TBI is linked to an increased risk for hypertension, stroke, diabetes, as well as neurological and psychiatric...
Guidelines
First-ever best practices for percutaneous axillary access
A new position statement from the Society for Cardiovascular Angiography and Interventions suggests best practices for this increasingly...
From the Journals
USPSTF final recommendation on aspirin for primary CV prevention
“Close reading of the new USPSTF guideline and its companion Evidence Review, and becoming familiar with the 3 more recent aspirin trials, is a...
From the Journals
Icosapent ethyl’s CV mortality benefit magnified in patients with prior MI
On top of statin therapy, icosapent ethyl provides mortality reductions in patients with prior MI.